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The Ia antigens are defined as cell-surface alloantigens determined by genes 
in the I region of the major histocompatibility complex (MHC) (1). 1 This defini- 
tion can probably only be rigorously applied to the mouse, since in no other 
species has a  distinct I  region been unambiguously mapped. However, a  large 
number of genetic, structural,  and functional characteristics have now been 
associated with murine Ia antigens, and these may serve as correlative criteria 
to identify Ia-like antigens in other species. Among these characteristics are: (a) 
genetic association with the MHC  (2,  3);  (b) tissue distribution,  in particular 
absence from platelets and relative abundance on B cells (4-6);  (c) association 
with the Fc  receptor of B  lymphocytes (7); (d)  chemical characterization as 
complex glycoproteins with subunits of mol wt approximately 28,000 and 35,000 
(8); (e) presence on T-cell factors (9-11);  and (D close association or identity to 
MLC-stimulating determinants (12, 13). With one or more of these criteria, Ia- 
like antigens have now been described in a variety of species including man (14- 
16 a), monkey (17), guinea pig (18), and rat (19, 20). Nevertheless, production and 
characterization of Ia-specific antisera in species other than mice is technically 
difficult and prone to problems of interpretation. It was thus for both theoretical 
and practical reasons that we were intrigued by the chance observation of an Ia 
specificity apparently  shared between certain strains  of mice  and rats.  The 
characterization of this interspecies cross-reactive Ia antigen is the subject of 
this paper. 
Materials and Methods 
Animals.  Mice were either purchased from The Jackson Laboratory,  Bar Harbor,  Maine or 
were raised in our own animal colonies. Adult female BN rats were purchased from Microbiologi- 
cal Associates, Bethesda,  Md. 
Serology.  Antisera  were  prepared  by  multiple  weekly  intraperitoneal  injections  of  live 
lymphoid cells or, in the case of ATH anti-ATL antiserum, by skin grafting followed by intraperi- 
toneal injections of lymphoid cells, both as previously described (21). 
Cytotoxicity assays were performed in disposable U plates (Cooke Laboratory Products Div., 
Alexandria, Va.), and percent lysis was determined by uptake of trypan blue dye, as previously 
described (21). Quantitative absorptions of sera were performed by first determining the number 
of cells necessary to clear cytotoxic activity against target cells of the absorbing strain, and then 
using twice this concentration of cells for the absorption of a larger sample of antiserum.  Serum 
1Abbreviations  used  in  this paper:  MHC,  mouse  histocompatibility  complex;  SDS,  sodium 
dodecyl sulfate. 
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and cells were mixed in Eppendorf 3810 centrifuge tubes for 30 min at 4°C and then centrifuged at 
15,000 rpm for 2 min in a Brinkman microcentrifuge (Brinkman Instruments, Inc., Westbury, N. 
Y.). 
Enriched Subpopulations of  Lymphoid Cells.  Splenic lymphocyte preparations were separated 
into populations enriched for T cells (nonadherent)  or for B cells (adherent)  by fractionation on 
nylon wool columns according to published methods (22, 23). The percentage of immunoglobulin- 
bearing cells in each population was evaluated by using fluorescein-conjugated rabbit anti-mouse 
Ig or rabbit anti-rat Ig reagents purchased from Cappel Laboratories Inc., Downingtown, Pa. The 
percentage of cells staining was determined by alternate phase and fluorescence microscopy by 
using a  Leitz Orthoplan microscope. (E. Leitz, Inc., Rockleigh, N. J.) 
Isolation  of Labeled  Cell  Surface Antigens.  Spleen cell surface  antigens  were  radiolabeled 
with  [3H]leucine and isolated by published methods  (8).  Briefly, spleen cells (5  x  107/ml) from 
either B10.BR mice or BN rats were incubated at 37°C for 5 h in leucine-free medium (RPMI 1640 
[National Institutes of Health Media Unit] supplemented with glutamine) including 200/~Ci/ml 
of [3H]leucine (New England Nuclear, Boston, Mass.).  After incubation,  cells were pelleted and 
resuspended in NP40 buffer solution (0.15  M NaC1, 0.01 M Tris pH 7.4,  containing 0.5% non-Idet 
P-40,  Particle  Data  Inc.,  Elmhurst,  Ill.).  After a  30-min  incubation  at 4°C  in  this  buffer,  the 
suspensions were centrifuged at 100,000 g  for 1 h. The supernate  was harvested and purified by 
affinity  chromatography  on  a  lentil  lectin  column  by  published  methods  (24).  Antigen  was 
eluted with 0.1 M a-methylmannoside in the same buffer, and concentrated by absorption to DE52 
cellulose (Whatman Inc., Clifton, N. J.) at pH 8.8 in 0.01 M NaC1, 0.25% NP40 followed by elution 
in 0.01 M Tris, pH 8.4,  0.4 M NaCI, 0.25% NP40. Aliquots of the concentrated antigens were then 
pretreated with Staphylococcus  aureus  Cowan I strain to remove endogenously labeled IgG. 
Indirect immunoprecipitation was carried out by using S. aureus  Cowan I strain fixed bacteria 
as the precipitating agent,  (25, 26). Precipitated immune complexes were eluted by boiling in 2% 
sodium dodecyl sulfate (SDS) containing 2% mercaptoethanol, and were analyzed by electrophore- 
sis on 10% polyacrylamide SDS gels. Gels were frozen and sliced into 2-ram sections. Slices were 
placed in  liquid scintillation  fluid  (Toluene containing  Omnifluor and  Protosol,  New  England 
Nuclear),  and  radioactivity was  determined in a  Beckman  LS 255  liquid scintillation counter. 
(Beckman Instruments,  Inc., Cedar Grove, N. J.) 
Results 
Detection of Serologic Cross-Reactions.  The  initial  observation  of Ia-like 
cross-reactivity between mice and rats was made during the serologic examina- 
tion of a xenospecific antiserum, B10.D2 anti-BN, in which anti-AgB.3 activity 
has previously been demonstrated (27). As a specificity control, a mouse alloan- 
tiserum made in the same strain was required, and an available B10.D2  anti- 
B10. BR antiserum was chosen. Unexpectedly, the control antiserum produced a 
cytotoxicity pattern on BN rat splenic target cells similar to what one might 
expect for an anti-Ia antiserum; that is, it produced a  plateau level killing of 
about one half of the targets (Fig. 1). 
If indeed this cytotoxic reactivity were due to a shared specificity between BN 
rats and B10.BR mice it was reasoned that the reactivity should be detectable in 
the reverse direction as well. The xenoantiserum B10.D2 anti-BN was therefore 
tested for cytotoxic reactivity against B10.BR splenic target cells. As shown in 
Fig. 2, a similar pattern of reactivity was observed, the B10. D2 anti-BN xenoan- 
tiserum showing plateau killing in this case, while the alloantiserum B10.D2 
anti-B10.BR showed the expected complete lytic potential of an H-2 antiserum. 
To assure that the reactions observed represented real cross-reactions rather 
than contamination of the  antisera,  absorption  analyses were performed. As 
seen in Table I, absorption with B10.BR cells removed all allo and xenoreactiv- 
ity from the alloantiserum B10.D2  anti-B10.BR, and absorption with BN cells 
removed all allo and xenoreactivity from the xenoantiserum B10.D2  anti-BN. D.  H.  SACHS,  G.  W.  HUMPHREY,  AND  J.  K.  LUNNEY  383 
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FIG.  1.  Cytotoxicity assays of three B10.D2  sera on BN splenic target cells. The B10.D2 
anti-B10.BR  antiserum  was  found  to  produce  an  expected Ia-like  cytotoxicity pattern 
(plateau lysis of approximately 50%) on the BN splenic target cells. Complement control 
was 17%. 
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FIG.  2.  Cytotoxicity titers  of  BI0.D2 allo  and xenoantisera on BI0.BR splenic target cells. 
A cross-reaction analogous to that seen in Fig. 1 is  here demonstrated for  the xenoantiserum 
tested on B10.BR mouse splenic target cells.  Complement  control was less  than 10%. 384  SHARING  OF  Ia  ANTIGENS  BETWEEN  SPECIES 
TABLE  I 
Absorption of Cross-Reacting Antibodies 
Resid- 
Serum  Absorbing cells 
(number/ml)  Target cells  ual ti- 
ter-'* 
B10.D2 a-B10.BR 
B10.D2  a-BN 
0  B10.BR  128 
BN  64 
B10.BR (5  ×  109  )  B10.BR  <2 
BN  <2 
0  B10.BR  128 
BN  512 
BN  (10 '°)  B10.BR  <2 
BN  <2 
* Residual titers taken as last dilution producing greater than half the 
maximum killing obtained on the same targets by unabsorbed serum. 
These results indicated that the cross-reactions observed did not result from 
contamination. 
Mapping  Studies.  Since  the  alloantiserum B10.D2  anti-B10.BR  was  pro- 
duced between congenic resistant strains presumed to differ only at H-2,  the 
cross-reactive specificity in this serum was thought likely to be directed against 
antigens determined by the  MHC of the rat,  which cross-reacted with MHC 
antigens of the  mouse.  Conversely, the antigen detected by B10.D2  anti-BN 
antiserum on B10.BR cells could be explained by cross-reactivity of a rat antigen 
with the allele of an H-2-1inked antigen of mice present on B10.BR (H-2 ~) and 
not  on  B10.D2  (H-2 d)  lymphocytes. The  availability of numerous  congenic 
resistant and congenic recombinant strains of mice made it feasible to attempt 
mapping studies on this cross-reactive specificity in the mouse. Table II shows a 
limited strain distribution of the reactivity of the B10.D2  anti-BN antiserum 
with mouse spleen cells. Of the strains tested, negative results were obtained in 
those bearing 1-t-2 d and H-2 b haplotypes and in those bearing the H-2 ° and H-2 ~ 
recombinant H-2  haplotypes in  which the  left end  of the H-2  complex  was 
derived from H-2 d and H-2 b,  respectively. These results thus indicate that the 
cell surface antigens responsible for these cross-reactions were determined by 
genes to the left of the S  region of H-2. 
Because H-2" strains were positive with this antiserum, the direct reactions of 
the H-2 t recombinant haplotypes were not informative for purposes of mapping 
the relative genes. Absorptions with A.SW (H-2') were therefore performed. As 
seen in Table III, after complete absorption with A. SW, both H-2" strains as well 
as the B10.HTT (H-2 t3) strain were negative, while residual anti-Ia like killing 
was still observed on B10.BR (H-2 k) and A.TL (H-2tl). These absorption studies 
therefore indicate that at least part of the anti-Ia-like cross-reactivity must be 
directed toward the product of genes to the right of the K region. Since the titer 
of the antiserum was lowered considerably by this absorption, there must have 
been at least two separable cross-reactive specificities in the B10.D2  anti-BN 
antiserum. While the specificity removed by absorption with A.SW cells was 
most likely also determined by an I region gene, no definitive left-hand bound- 
ary can yet be inferred (i.e., it could also be in or to the left of the K region). D.  H.  SACHS,  G.  W.  HUMPHREY,  AND  J.  K.  LUNNEY  385 
TABLE  II 
Strain Distribution of Reactivity 
Maximum 
Strain  H-2 Type  Titer  -I 
specific  lysis 
% 
B10  b  <2  6 
B10.A  a  16  45 
B10.A(2R)  h2  32  50 
B10.A(4R)  h4  32  43 
B10.A(5R)  i5  <2  1 
B10.BR  k  32  56 
C3H.OL  o  <2  2 
B10.S  s  16  50 
A. SW  s  32  46 
B10.HTT  t3  8  30 
A.TL  tl  64  46 
B10.D2  d  <2  0 
The xenoantiserum B10.D2  anti-BN was tested in a  complement-me- 
diated cytotoxicity assay on spleen cell targets of each strain indicated. 
Titers are expressed as reciprocal of last dilution producing greater than 
50% of the maximum  specific lysis. Complement controls were generally 
less than 15% and have been subtracted. 
TABLE  HI 
Effect of Absorption with A.SW 
Strain  H-2 Type 
Before absorption  After absorption 
Titer  -I  Lysis  Titer  -I  Lysis 
%  % 
A. SW  s  32  46  <2  0 
B10.S  s  16  50  <2  0 
A.TL  tl  64  46  8  39 
B10.HTT  t3  8  30  <2  0 
B10.BR  k  32  56  8  42 
The xenoantiserum B10.D2 anti-BN was quantitatively absorbed with 
A,SW spleen cells as described in the text. Titers and percent lysis are 
explained in legend to Table I. 
Table IV summarizes the serologic mapping studies thus far. Arrows indicate 
the boundaries on the responsible genes inferred from each result. These data 
indicate that at least some, if not all, of the cross-reactive Ia-like specificities in 
the B10. D2 anti-BN antiserum tested on mouse cells is directed toward products 
of genes in the/-A subregion. It should be emphasized that negative results on a 
strain bearing part of the H-2 haplotype of a  positive strain (e.g.  C3H.0L and 
B10.A[5R]) imply definitive boundaries for mapping. However, positive results 
in a  recombinant H-2  haplotype only imply that part of the reactivity can be 
mapped as indicated by the arrows (e.g. B10.A[2R] and A.TL). Thus, from the 
direct testing of B10.A(2R) and B10.A(5R) shown in Table IV, one can infer that 
genes in or to the left of the I-B subregion must be responsible for the reactivity 
and that at least part of the reactivity is against a product of a gene located to 386  SHARING  OF  Ia  ANTIGENS  BETWEEN  SPECIES 
TABLE  IV 
Mapping of la Reactivity 
Absorption  Reactivity  Strain  with: 
Position inferred 
K  I-A  I-B  I-J  I-E  I-C  S  D 
B10  0  -  b  b  b  b  b  b  b  b 
B10.D2  0  -  d  d  d  d  d  d  d  d 
B10.A  0  +  k  k  k  k  k  d  d  d 
B10.BR  0  +  k  k  k  k  k  k  k  k 
B10.A(2R)  0  +  k  k  k  k  k  d  d  d  b 
T 
B10.A(4R)  0  +  k  k  ]  b  b  b  b  b  b 
I 
B10.A(5R)  0  -  b  b  b  t  k  k  d  d  d 
L 
B10.BR  B10.A(4R)  -  k  k  I  k  k  k  k  k  k 
I 
A.TL  A.SW  +  s  |  k  k  k  k  k  k  d 
[  ) 
B10.HTT  A.SW  -  s  s  s  s  |  k  k  k  d 
i 
C3H.OL  0  -  d  d  d  d  d  d  |  k  k 
(  i 
The presumed haplotype of origin of each H-2 subregion is indicated by a small letter in the table. 
Arrows indicate the  position of the  gene(s) determining reactivity relative to the  position of 
crossover in recombinant haplotypes. Only experimentally produced recombinants (and not the 
H-2 a presumed recombinant) have been used for mapping. 
the left ofI-B. To exclude I-B antigens  as also being detected an absorption was 
necessary.  Thus,  the failure to find reactivity on B10.BR  after absorption with 
B10.A(4R),  also shown  in Table IV, places a  right-hand  boundary  to the left of 
the I-B subregion. 
Testing of Fractionated Spleen Cells.  One of the principle characteristics of 
Ia antigens  is their preferential expression on B  lymphocytes, in contrast to the 
ubiqitous expression of K  and D  antigens  (5). It is now clear that Ia antigens  are 
expressed on certain T-cell populations as well (28-30). However, due either to a 
lower quantity  of Ia antigens  (less than  10%) or to steric properties, the cytotox- 
icity of most  anti-Ia antisera  is  almost  exclusively directed toward  the  B-cell 
subpopulation. 
We  therefore  examined  the  cross-reactive  specificities  described  above  on 
spleen cell populations fractionated  on nylon wool.  Table V  shows  the  results 
obtained in three representative  experiments. A  comparison of the percentage of 
immunoglobulin-positive  cells in  each  subpopulation  with  the  maximum  per- 
cent lysis obtained in that subpopulation  suggests that the majority of the lysis 
of unseparated  spleen cells by the  cross-reactive antisera  was  due  to  selective 
lysis of B  cells.  While  these  results  are  similar  to  what  has  previously  been 
described for anti-Ia reactions  (5),  there  was  low but  significant killing of the 
nonadherent  (T-cell)  population  (15-29%  in  eight  experiments),  for  both  the 
B10.D2  anti-BN  serum  tested  on  B10.BR  and  the  B10.D2  anti-B10.BR  serum 
tested on BN. This level of killing ofT cells is in excess of what is generally seen D.  H.  SACHS,  G.  W.  HUMPHREY,  AND  J.  K.  LUNNEY  387 
TABLE  V 
Cross-Reactivities on Fractionated Cells 
Comple-  Maximum 
Experi-  Target cells  Ig+  Serum tested  ment con- 
merit  trol  lysis 
%  %  % 
1  B10.BR (pre)  59  B10.D2  a-B10.BR  <10  >90 
B10.D2  a-BN  <10  70 
B10.BR (Adh)  89  Bt0.D2 a-B10.BR  <10  >90 
B10.D2  a-BN  <10  87 
B10.BR (NA)  10  B10.D2  a-B10.BR  12  >90 
B10.D2  a-BN  11  40 
2  B10.BR (pre)  57  A.TH a-A.TL  <10  66 
B10.D2  a-BN  <10  69 
B10.BR (Adh)  88  A.TH a-A.TL  <10  90 
B10.D2  a-BN  <10  94 
B10.BR (NA)  10  A.TH a-A.TL  14  16 
B10.D2 a-BN  11  39 
3  BN (pre)  59  B10.D2  a-BN  12  >90 
B10.D2  a-B10.BR  15  58 
BN (Adh)  76  B10.D2  a-BN  <10  >90 
B10.D2  a-B10.BR  <10  84 
BN (NA)  4  B10.D2  a-BN  18  >90 
B10.D2  a-B10.BR  15  33 
Spleen cells from B10.BR (experiments 1 and 2) or BN (experiment 3) animals were tested with the 
antisera shown, unfractionated (pre) or after fractionation into nylon nonadherent (NA)  and 
adherent (Adh) populations. Complement controls are shown and have not been subtracted from 
maximal lysis. 
for murine  Ia  antisera  (3). That  this  was  not  due  to  technical aspects,  for 
example increased sensitivity of  the nonadherent cell population to complement- 
mediated killing is evidenced by the comparison with a  known anti-Ia antise- 
rum (A.TH anti-A.TL) shown in experiment two. In this experiment the B10.D2 
anti-BN antiserum showed 28%-specific  lysis of B10.BR nonadherent cells while 
the A.TH anti-A.TL antiserum produced only about 2% specific lysis. Similar 
levels of lysis of nonadherent spleen cells were obtained by using the B10.D2 
anti-BN antiserum on A.TL fractionated lymphocytes after absorption of the 
antiserum with A.SW, again confirming that the relevant genes determining 
this specificity were in the/region (data not shown). It thus appeared that while 
the cross-reactive specificities were to antigens expressed predominantly on B 
cells, there was also sufficient expression of the relative antigens on certain T 
cells to lead to specific complement-mediated lysis. 
Chemical Isolation Studies.  Another criterion which we have examined in 
attempting to characterize this Ia-like cross-reactivity between the mouse and 
the rat,  is the chemical nature of the responsible cell surface antigens. In the 
mouse,  anti-Ia antisera have been shown to precipitate cell surface glycopro- 
teins of mol wt of approximately 35,000 and 28,000, as distinct from H-2 antigens 
which appear to be 45,000 mol wt glycoproteins (8). We have therefore analyzed 
both the B10.D2 anti-BN and B10.D2 anti-B10.BR antisera for their reactivities 
with labeled mouse and rat cell surface antigen preparations. The results are 388 
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FIG.  3.  SDS gel analyses of shared Ia specificities. The three panels show the reactivity of 
an alloantiserum (B10.D2 anti-B10.BR),  a xenoantiserum  (B10.D2 anti-BN) and a normal 
serum  (normal  B10.D2)  with cell  surface  antigen  preparations  from  BN  rat  and  B10.A 
mouse splenic lymphocytes,  as indicated in the figure.  The Ia peaks form a  characteristic 
doublet at about 4.5 and 5.5 cm of gel, indicating mol wt of approximately 35,000 and 28,000, 
respectively.  The slight leftward displacement of all peaks in the first gel  (alloantiserum 
tested on BN antigen) was due to a slicing artifact on that gel and was not seen in multiple 
replicate gels in this system. 
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shown  in  Fig.  3.  When  tested  on  B10.A  antigen,  the  B10.D2  anti-B10.BR 
alloantiserum produced peaks of the three mol wt expected for H-2 (45,000)  and 
Ia  (35,000  and  28,000)  antigens,  which should  be  detected  by this  antiserum 
when  tested  on  cells  of the  B10.A  strain.  When  tested  on  the  BN  antigen 
preparation,  however,  only  2  Ia-like  peaks  were  observed.  Conversely,  the 
xenoantiserum  B10.D2  anti-BN  precipitated  only  peaks  corresponding  to  Ia 
antigens when tested on the mouse cell surface preparation, but produced peaks 
of a variety of sizes when tested on the BN rat cell surface preparation. Control 
precipitations  with  normal  sera  were  negative  on  both  preparations,  as  ex- 
pected. It thus appeared by chemical criteria that the cross-reactive specificities 
were directed against Ia antigens of the mouse, and by analogy, against Ia-like 
antigens of the rat. 
Discussion 
By a variety of criteria, the cross-reactions described in this paper appear to 
detect Ia antigenic determinants shared between the two species examined. We 
have demonstrated these Ia-like reactions to be true cross-reactions by immuni- 
zation in both directions (i.e., mouse anti-rat antisera tested on mouse cells and 
mouse anti-mouse antisera tested on rat cells) as well as by absorption analyses 
of the immune sera.  Cross-reactions between H-2 antigens and the HLA anti- 
gens of man have previously been reported both on the basis of reactivities of 
mouse  alloantisera  with  panels  of human  cells  (31)  and  on  the  basis  of the D.  H.  SACHS,  G.  W.  HUMPHREY~  AND  J.  K.  LUNNEY  389 
reactivities of a rabbit anti-HLA antiserum with mouse lymphocytes (32). These 
cross-reactions have generally been ascribed to sharing of H-2-1ike rather than 
Ia-like  specificities,  although  chemical  isolation  studies  have  not  been  per- 
formed.  Chemical analyses of the cross-reactions described in this paper,  indi- 
cate the detection of only Ia-like and not H-2-1ike antigens. A cross-reaction of a 
rabbit anti-HLA-D antiserum with what appeared to be mouse Ia antigens on 
SDS gels has also been reported recently (33). 
Attempts to explain the basis for these interspecies cross-reactions raise some 
perplexing theoretical  questions,  the answers to which seem worth pursuing, 
since they may provide  insights  to the  evolution of these  complex  antigenic 
systems. The entire MHC appears by genetic, structural, and functional criteria 
to be very similar among a variety of mammalian species, suggesting evolution 
of this gene complex from common primordial genes. By analogy to the immuno- 
globulin structural genes, one might expect that during evolution portions of  the 
genes determining the MHC antigens may have been conserved for functional 
reasons, despite our inability at present to discern the natural  function of the 
products  of this  locus.  Alloantigenic  specificities,  on  the  other  hand,  imply 
polymorphism within a species, and usually result from divergence of sequences 
at regions of a molecule which are not critical to the natural function of the gene 
product. 
We are thus faced with an apparent contradiction. If the shared Ia specificities 
we  have  detected  resulted  from  conservation  of genetic  information  during 
evolution, then the structural determinants concerned should not also be alloan- 
tigens  within  these  species.  We  can  envision  two  hypotheses  which  might 
resolve this apparent contradiction. 
First, the genetic information in question may be prone to great divergence, 
which could have led to extensive polymorphism in both species. By this line of 
reasoning,  the observed cross-reactions would reflect convergent evolution, the 
random appearance of structurally similar alloantigens among the repertoire of 
allotypic variants of the two species. 
Second, it seems possible that the portion of the Ia molecule responsible for 
this shared antigenic determinant has been conserved during the evolution, but 
that the conservation has been incomplete.  For example, divergence may have 
been permitted in the mouse because of another, separate mutation which led to 
relaxation of the mutational restrictions on the sequence in question. Then the 
sequence in one of the mouse alleles (I-A  k) would be similar to the primordial 
sequence which is still maintained in the rat. Alternatively, this sequence could 
be  slowly diverging  in  all  species  and  the  shared  specificity detected would 
reflect the common primordial sequence from which each species is diverging. In 
either case, the observed cross-reaction would be the result of limited polymor- 
phism and divergent evolution. 
In distinguishing between these two hypotheses it is important to note that we 
have  so  far  determined  an  alloantigenic  distribution  for  the  cross-reacting 
specificity only in the  mouse.  All three  rat  strains  we have  so far examined 
(BN[AgB3],  Lewis  [AgB1]  and  DA  [AgB4])  have  reacted  similarly  with  the 
B10. D2 anti-B10.BR antiserum.  Whether or not alloantigenic differences can be 
distinguished between the cross-reacting determinants of different rat strains is 
presently being examined, both by differential absorption studies and by the use 390  SHARING  OF  Ia  ANTIGENS  BETWEEN  SPECIES 
of different allo and xenoantisera.  However, at present the apparent similarity 
of this specificity in the three rat strains tested favors the hypothesis of diver- 
gent  rather  than  convergent  evolution  to  explain  the  origin  of these  cross- 
reactions.  Examination  of the extent of polymorphism in Ia-like cross-reactivi- 
ties between mouse and other species (several of which we are presently study- 
ing) should help to resolve these questions further. 
It  should  be  emphasized  that  the  allelic  distribution  of the  cross-reactive 
specificity in the mouse has permitted definitive mapping studies which indicate 
that  the  cross-reacting  antigen  is  indeed  an  Ia  antigen  (i.e.,  determined  by 
genes mapping in the I region of the MHC). However, since all three rat strains 
were similarly reactive with the B10. D2 anti-B10.BR antiserum,  formal genetic 
mapping studies are not yet possible in the rat.  Thus,  although criteria tested 
indicate that the antigens detected in the rat are analogous to Ia antigens of the 
mouse,  it  remains  possible  (but  unlikely)  that  the  genes  responsible  for the 
cross-reacting molecules in the rat could be other than MHC linked.  Coprecipi- 
tation  analyses with known anti-rat  Ia antisera  and mapping  studies in other 
species are currently in progress to assess MHC linkage. 
In addition to these theoretical questions, there are several practical aspects 
to this work that we consider important  for further development.  First,  if the 
sharing  of Ia  alloantigenic  specificities  is  a  general  phenomenon,  it  could 
provide a new and readily available means of obtaining anti-Ia reagents both for 
typing and for functional studies in other species, including man. Second, these 
cross-reacting  reagents  may detect different I  region products  than  those de- 
tected by alloantisera,  and could thus help to further dissect the fine structure of 
the Ia genes. For example, the mapping studies we have performed in the mouse 
have indicated that the cross-reactive specificity detected is determined by genes 
in the I-A  subregion (Table IV). It should be possible to determine by chemical 
precipitation  studies  whether  or  not  this  specificity is  present  on  the  same 
molecule as other I-A  subregion specificities of the H-2 k haplotype.  Failure of 
preprecipitation with the cross-reactive specificity to cause complete precipita- 
tion of all I-A  k antigens  (or vice versa) would indicate that there is more than 
one gene product determined by the I-A  subregion. 
Finally,  the  observation that  the  interspecies  cross-reactive  Ia  specificities 
appear to be more readily detectable on certain T cells than are alloantigenic Ia 
specificities, may also be of practical importance. These cross-reactive reagents 
could provide important tools for functional studies in which the effects of anti- 
Ia antisera on T-cell populations are to be examined.  It will also be of interest 
to examine the effects of these antisera on T-cell factors which have been shown 
to bear Ia antigens  (9-11). 
Summary 
A  mouse anti-rat xenogeneic antiserum,  B10.D2 anti-BN,  has been found to 
react  with  a  subpopulation  of lymphoid  cells  of certain  mouse  strains.  The 
corresponding alloantiserum, B10.D2 anti-B10.BR, reacted in analogous fashion 
with lymphoid cells of BN rats. In the case of the cross-reaction on mouse cells, 
mapping  studies  indicated  that  at  least  part  of the  reactivity  was  with  the 
product of gene(s) determined by the I-A subregion of the H-2 complex. Chemi- D.  H.  SACHS,  G.  W.  HUMPHREY,  AND  J.  K.  LUNNEY  391 
cal isolation  studies with radiolabeled cell surface preparations indicated  that 
the  antigens  detected  in  both  mouse  and  rat had  mol wt  characteristic  of Ia 
antigens  (35,000  and  28,000  dalton  molecules).  Testing  of fractionated  spleen 
cell populations  revealed that  the  cross-reactive antigens  were expressed pre- 
dominantly on B  cells,  but that  a  subpopulation of T  cells were also reactive. 
Wider strain and species distribution  studies  are in progress to determine the 
extent  of such  Ia  cross-reactions  between  species  and  to  further  assess  the 
practical and theoretical importance of such cross-reactions. 
We thank Ms. Judith A. Steckel  for expert secretarial assistance. 
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